Subject category:
Entrepreneurship
Published by:
Harvard Business Publishing
Version: 25 October 2013
Revision date: 18-Jun-2014
Length: 26 pages
Data source: Generalised experience
Share a link:
https://casecent.re/p/108096
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
In March 2010, US District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues deal with the potential implications of Judge Sweet's decision for biotechnology entrepreneurs and investors.
About
Abstract
In March 2010, US District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues deal with the potential implications of Judge Sweet's decision for biotechnology entrepreneurs and investors.